An Epithelial-to-Mesenchymal transcriptional switch triggers evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and identifies dasatinib as new therapeutic option

Gloria Manzotti, Federica Torricelli, Benedetta Donati, Filippo Lococo, Valentina Sancisi, Giulio Rossi, Simonetta Piana, Alessia Ciarrocchi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'An Epithelial-to-Mesenchymal transcriptional switch triggers evolution of Pulmonary Sarcomatoid Carcinoma (PSC) and identifies dasatinib as new therapeutic option'. Together they form a unique fingerprint.

Medicine & Life Sciences